Retension Pharmaceuticals
RTSN12.2700.16% ( +0.020 )
已收盤: 11月13日 16:00:00 (美東)股東
全部股東
股東類型
- 公眾及其他54.35%
- 個人與內幕人士23.62%
- 機構投資者12.03%
- 對沖基金10.00%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
PVG Asset Management Corp | 12.03% | 100.21 萬 | -- | +100.21 萬 | |
The B Group, Inc. | 10.00% | 83.33 萬 | -- | +83.33 萬 | 13/10/2026 |
Laurence Lytton | 7.41% | 61.72 萬 | -- | +61.72 萬 | 13/10/2026 |
Eric KellerCo-founder, CEO & Director | 5.57% | 46.44 萬 | -- | +46.44 萬 | 13/10/2026 |
Craig SincockFormer Director | 5.26% | 43.85 萬 | -- | +43.85 萬 | |
Paul SweetnamCo-Founder, Chief Scientific Officer & Secretary | 4.91% | 40.92 萬 | -- | +40.92 萬 | 13/10/2026 |
Franklin BergerIndependent Director | 0.27% | 2.25 萬 | -- | +2.25 萬 | 13/10/2026 |
Michael BerendtExecutive Chairman | 0.08% | 6,666.00 | -- | +6,666.00 | 13/10/2026 |
Donald OldsIndependent Director | 0.07% | 5,637.00 | -- | +5,637.00 | 13/10/2026 |
Sabine BissonChief Operations Officer | 0.05% | 4,115.00 | -- | +4,115.00 | 13/10/2026 |